Joel Greenblatt Alnylam Pharmaceuticals, Inc. Transaction History
Gotham Asset Management, LLC
- $10.2 Billion
- Q4 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 10,924 shares of ALNY stock, worth $2.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,924
Previous 17,575
37.84%
Holding current value
$2.8 Million
Previous $4.83 Million
46.83%
% of portfolio
0.03%
Previous 0.05%
Shares
17 transactions
Others Institutions Holding ALNY
# of Institutions
673Shares Held
112MCall Options Held
943KPut Options Held
922K-
Capital World Investors Los Angeles, CA16.6MShares$4.26 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.27 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.45 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.79 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.12 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...